Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Increased Cardiovascular Disease Risk in Veterans With Mental Illness.

Vance MC, Wiitala WL, Sussman JB, Pfeiffer P, Hayward RA.

Circ Cardiovasc Qual Outcomes. 2019 Oct;12(10):e005563. doi: 10.1161/CIRCOUTCOMES.119.005563. Epub 2019 Sep 24.

PMID:
31547692
2.

Web Exclusive. Annals On Call - Statins for Primary Prevention: Finding the Balance.

Centor RM, Sussman JB.

Ann Intern Med. 2019 Apr 2;170(7):OC1. doi: 10.7326/A19-0002. No abstract available.

PMID:
30934086
3.

Estimation of global insulin use for type 2 diabetes, 2018-30: a microsimulation analysis.

Basu S, Yudkin JS, Kehlenbrink S, Davies JI, Wild SH, Lipska KJ, Sussman JB, Beran D.

Lancet Diabetes Endocrinol. 2019 Jan;7(1):25-33. doi: 10.1016/S2213-8587(18)30303-6. Epub 2018 Nov 21. Erratum in: Lancet Diabetes Endocrinol. 2019 Jan;7(1):e1.

PMID:
30470520
4.

Of Barbershops and Churches.

Sussman JB, Heisler M.

Circ Cardiovasc Qual Outcomes. 2018 Oct;11(10):e005149. doi: 10.1161/CIRCOUTCOMES.118.005149. No abstract available.

5.

Implications of True and Perceived Treatment Burden on Cardiovascular Medication Use.

Sussman JB, Schell GJ, Lavieri MS, Hayward RA.

MDM Policy Pract. 2017 Dec 22;2(2):2381468317735306. doi: 10.1177/2381468317735306. eCollection 2017 Jul-Dec.

6.

Generalizing Intensive Blood Pressure Treatment to Adults With Diabetes Mellitus.

Berkowitz SA, Sussman JB, Jonas DE, Basu S.

J Am Coll Cardiol. 2018 Sep 11;72(11):1214-1223. doi: 10.1016/j.jacc.2018.07.012.

7.

Clinical Implications of Revised Pooled Cohort Equations for Estimating Atherosclerotic Cardiovascular Disease Risk.

Yadlowsky S, Hayward RA, Sussman JB, McClelland RL, Min YI, Basu S.

Ann Intern Med. 2018 Jul 3;169(1):20-29. doi: 10.7326/M17-3011. Epub 2018 Jun 5.

PMID:
29868850
8.

Designing for Clinical Change: Creating an Intervention to Implement New Statin Guidelines in a Primary Care Clinic.

DeJonckheere M, Robinson CH, Evans L, Lowery J, Youles B, Tremblay A, Kelley C, Sussman JB.

JMIR Hum Factors. 2018 Apr 24;5(2):e19. doi: 10.2196/humanfactors.9030.

9.

Validation of Risk Equations for Complications of Type 2 Diabetes (RECODe) Using Individual Participant Data From Diverse Longitudinal Cohorts in the U.S.

Basu S, Sussman JB, Berkowitz SA, Hayward RA, Bertoni AG, Correa A, Mwasongwe S, Yudkin JS.

Diabetes Care. 2018 Mar;41(3):586-595. doi: 10.2337/dc17-2002. Epub 2017 Dec 21.

10.

An Examination of Deintensification Recommendations in Clinical Practice Guidelines: Stepping Up or Scaling Back?

Markovitz AA, Hofer TP, Froehlich W, Lohman SE, Caverly TJ, Sussman JB, Kerr EA.

JAMA Intern Med. 2018 Mar 1;178(3):414-416. doi: 10.1001/jamainternmed.2017.7198. No abstract available.

11.

Effects of Guideline and Formulary Changes on Statin Prescribing in the Veterans Affairs.

Markovitz AA, Holleman RG, Hofer TP, Kerr EA, Klamerus ML, Sussman JB.

Health Serv Res. 2017 Dec;52(6):1996-2017. doi: 10.1111/1475-6773.12788.

12.

Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials.

Basu S, Sussman JB, Rigdon J, Steimle L, Denton BT, Hayward RA.

PLoS Med. 2017 Oct 17;14(10):e1002410. doi: 10.1371/journal.pmed.1002410. eCollection 2017 Oct.

13.

Black-White Cardiovascular Disease Disparities After Target-Based Versus Personalized Benefit-Based Lipid and Blood Pressure Treatment.

Basu S, Sussman JB, Hayward RA.

MDM Policy Pract. 2017 Aug 17;2(2):2381468317725741. doi: 10.1177/2381468317725741. eCollection 2017 Jul-Dec.

14.

Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials.

Basu S, Sussman JB, Berkowitz SA, Hayward RA, Yudkin JS.

Lancet Diabetes Endocrinol. 2017 Oct;5(10):788-798. doi: 10.1016/S2213-8587(17)30221-8. Epub 2017 Aug 10.

15.

The Veterans Affairs Cardiac Risk Score: Recalibrating the Atherosclerotic Cardiovascular Disease Score for Applied Use.

Sussman JB, Wiitala WL, Zawistowski M, Hofer TP, Bentley D, Hayward RA.

Med Care. 2017 Sep;55(9):864-870. doi: 10.1097/MLR.0000000000000781.

16.

Corrected ROC analysis for misclassified binary outcomes.

Zawistowski M, Sussman JB, Hofer TP, Bentley D, Hayward RA, Wiitala WL.

Stat Med. 2017 Jun 15;36(13):2148-2160. doi: 10.1002/sim.7260. Epub 2017 Feb 28.

17.

Detecting Heterogeneous Treatment Effects to Guide Personalized Blood Pressure Treatment: A Modeling Study of Randomized Clinical Trials.

Basu S, Sussman JB, Hayward RA.

Ann Intern Med. 2017 Mar 7;166(5):354-360. doi: 10.7326/M16-1756. Epub 2017 Jan 3.

18.

Data-Driven Markov Decision Process Approximations for Personalized Hypertension Treatment Planning.

Schell GJ, Marrero WJ, Lavieri MS, Sussman JB, Hayward RA.

MDM Policy Pract. 2016 Oct 17;1(1):2381468316674214. doi: 10.1177/2381468316674214. eCollection 2016 Jul-Dec.

19.

Age Disparities in the Use of Steroid-sparing Therapy for Inflammatory Bowel Disease.

Govani SM, Wiitala WL, Stidham RW, Saini SD, Hou JK, Feagins LA, Sussman JB, Higgins PD, Waljee AK.

Inflamm Bowel Dis. 2016 Aug;22(8):1923-8. doi: 10.1097/MIB.0000000000000817.

20.

New Studies Do Not Challenge the American College of Cardiology/American Heart Association Lipid Guidelines.

Hofer TP, Sussman JB, Hayward RA.

Ann Intern Med. 2016 May 17;164(10):683-4. doi: 10.7326/M15-2428. Epub 2016 Feb 9. No abstract available.

PMID:
26857151
21.

Alternative Strategies to Achieve Cardiovascular Mortality Goals in China and India: A Microsimulation of Target- Versus Risk-Based Blood Pressure Treatment.

Basu S, Yudkin JS, Sussman JB, Millett C, Hayward RA.

Circulation. 2016 Mar 1;133(9):840-8. doi: 10.1161/CIRCULATIONAHA.115.019985. Epub 2016 Jan 13.

22.

Reply: Risk-based Heterogeneity of Treatment Effect in Trials and Implications for Surveillance of Clinical Effectiveness Using Regression Discontinuity Designs.

Iwashyna TJ, Burke JF, Sussman JB, Prescott HC, Hayward RA, Angus DC.

Am J Respir Crit Care Med. 2015 Dec 1;192(11):1399-400. doi: 10.1164/rccm.201508-1625LE. No abstract available.

23.

Three simple rules to ensure reasonably credible subgroup analyses.

Burke JF, Sussman JB, Kent DM, Hayward RA.

BMJ. 2015 Nov 4;351:h5651. doi: 10.1136/bmj.h5651. No abstract available.

24.

Rates of Deintensification of Blood Pressure and Glycemic Medication Treatment Based on Levels of Control and Life Expectancy in Older Patients With Diabetes Mellitus.

Sussman JB, Kerr EA, Saini SD, Holleman RG, Klamerus ML, Min LC, Vijan S, Hofer TP.

JAMA Intern Med. 2015 Dec;175(12):1942-9. doi: 10.1001/jamainternmed.2015.5110.

PMID:
26502220
25.

Stress Testing After Percutaneous Coronary Intervention in the Veterans Affairs HealthCare System: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.

Bradley SM, Hess E, Winchester DE, Sussman JB, Aggarwal V, Maddox TM, Barón AE, Rumsfeld JS, Ho PM.

Circ Cardiovasc Qual Outcomes. 2015 Sep;8(5):486-92. doi: 10.1161/CIRCOUTCOMES.114.001561. Epub 2015 Jul 21.

PMID:
26198400
26.

Implications of Heterogeneity of Treatment Effect for Reporting and Analysis of Randomized Trials in Critical Care.

Iwashyna TJ, Burke JF, Sussman JB, Prescott HC, Hayward RA, Angus DC.

Am J Respir Crit Care Med. 2015 Nov 1;192(9):1045-51. doi: 10.1164/rccm.201411-2125CP.

27.

Comparing the effectiveness of competing tests for reducing colorectal cancer mortality: a network meta-analysis.

Elmunzer BJ, Singal AG, Sussman JB, Deshpande AR, Sussman DA, Conte ML, Dwamena BA, Rogers MA, Schoenfeld PS, Inadomi JM, Saini SD, Waljee AK.

Gastrointest Endosc. 2015 Mar;81(3):700-709.e3. doi: 10.1016/j.gie.2014.10.033.

28.

Improving diabetes prevention with benefit based tailored treatment: risk based reanalysis of Diabetes Prevention Program.

Sussman JB, Kent DM, Nelson JP, Hayward RA.

BMJ. 2015 Feb 19;350:h454. doi: 10.1136/bmj.h454.

29.

Stress testing before low-risk surgery: so many recommendations, so little overuse.

Kerr EA, Chen J, Sussman JB, Klamerus ML, Nallamothu BK.

JAMA Intern Med. 2015 Apr;175(4):645-7. doi: 10.1001/jamainternmed.2014.7877. No abstract available.

30.

Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes.

Yudkin JS, Vijan S, Sussman JB, Lehman R, Goldacre BM.

Lancet. 2014 Sep 20;384(9948):1095. doi: 10.1016/S0140-6736(14)61671-8. No abstract available.

PMID:
25241716
31.

Evidence-based risk communication: a systematic review.

Zipkin DA, Umscheid CA, Keating NL, Allen E, Aung K, Beyth R, Kaatz S, Mann DM, Sussman JB, Korenstein D, Schardt C, Nagi A, Sloane R, Feldstein DA.

Ann Intern Med. 2014 Aug 19;161(4):270-80. doi: 10.7326/M14-0295. Review.

PMID:
25133362
32.

Effect of patients' risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus.

Vijan S, Sussman JB, Yudkin JS, Hayward RA.

JAMA Intern Med. 2014 Aug;174(8):1227-34. doi: 10.1001/jamainternmed.2014.2894.

33.

Rethinking the frequency of between-visit monitoring for patients with diabetes.

Piette JD, Aikens JE, Rosland AM, Sussman JB.

Med Care. 2014 Jun;52(6):511-8. doi: 10.1097/MLR.0000000000000131.

34.

Providing clinicians with a patient's 10-year cardiovascular risk improves their statin prescribing: a true experiment using clinical vignettes.

Sekaran NK, Sussman JB, Xu A, Hayward RA.

BMC Cardiovasc Disord. 2013 Oct 22;13:90. doi: 10.1186/1471-2261-13-90.

35.

Maximizing the value of mobile health monitoring by avoiding redundant patient reports: prediction of depression-related symptoms and adherence problems in automated health assessment services.

Piette JD, Sussman JB, Pfeiffer PN, Silveira MJ, Singh S, Lavieri MS.

J Med Internet Res. 2013 Jul 5;15(7):e118. doi: 10.2196/jmir.2582.

36.

Improving the reliability of physician "report cards".

Smith KA, Sussman JB, Bernstein SJ, Hayward RA.

Med Care. 2013 Mar;51(3):266-74. doi: 10.1097/MLR.0b013e31827da99c.

37.

Improved cardiovascular risk prediction using nonparametric regression and electronic health record data.

Kennedy EH, Wiitala WL, Hayward RA, Sussman JB.

Med Care. 2013 Mar;51(3):251-8. doi: 10.1097/MLR.0b013e31827da594.

38.

Cardiac risk is not associated with hypertension treatment intensification.

Sussman JB, Zulman DM, Hayward R, Hofer TP, Kerr EA.

Am J Manag Care. 2012 Aug;18(8):414-20.

39.

Time to stroke magnetic resonance imaging.

Burke JF, Sussman JB, Morgenstern LB, Kerber KA.

J Stroke Cerebrovasc Dis. 2013 Aug;22(6):784-91. doi: 10.1016/j.jstrokecerebrovasdis.2012.03.012. Epub 2012 Apr 26.

PMID:
22541605
40.

Effect of perioperative statins on death, myocardial infarction, atrial fibrillation, and length of stay: a systematic review and meta-analysis.

Chopra V, Wesorick DH, Sussman JB, Greene T, Rogers M, Froehlich JB, Eagle KA, Saint S.

Arch Surg. 2012 Feb;147(2):181-9. doi: 10.1001/archsurg.2011.897. Review.

PMID:
22351917
41.

Individual and population benefits of daily aspirin therapy: a proposal for personalizing national guidelines.

Sussman JB, Vijan S, Choi H, Hayward RA.

Circ Cardiovasc Qual Outcomes. 2011 May;4(3):268-75. doi: 10.1161/CIRCOUTCOMES.110.959239. Epub 2011 Apr 12.

42.

Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials.

Zulman DM, Sussman JB, Chen X, Cigolle CT, Blaum CS, Hayward RA.

J Gen Intern Med. 2011 Jul;26(7):783-90. doi: 10.1007/s11606-010-1629-x. Epub 2011 Feb 1. Review.

43.

Hospitals during recession and recovery: vulnerable institutions and quality at risk.

Sussman JB, Halasyamani LK, Davis MM.

J Hosp Med. 2010 May-Jun;5(5):302-5. doi: 10.1002/jhm.654. Review.

44.

Supplemental Content

Loading ...
Support Center